Letter to the Editor

Percutaneous Intervention of Left Main Coronary Artery Disease: A Fresh Look at a Class III Recommendation

Authors: Matthew J. Diamond, DO, Jaspal Gujral, MBBS, FACP, Deepak Kapoor, MD

Abstract

Percutaneous intervention of left main coronary artery (LMCA) disease is a class III recommendation per the latest guidelines published by the American Heart Association/American College of Cardiology.1 As techniques, technologies, research, and pharmaceuticals advance, intervention on LMCA disease has become a more feasible option. We present two cases, both with different indications, but sharing a common conclusion.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): executive summary. Circulation 2001;103:3019.
 
2. Marso SP, Steg G, Plokker T, et al. Catheter-based reperfusion of Unprotected Left Main Stenosis During Acute Myocardial Infarction (the ULTIMA experience). Am J Cardiol 1999;83:1513–1517.
 
3 Nayak AK, Davis R, Reddy HK, et al. Left main coronary artery rotational atherectomy and stenting.South Med J 2000;93:415–423.
 
4. Ellis SG, Tamani H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenosis. Circulation 1997;96:3867–3872